Premium
[P4–140]: HMG COA REDUCTASE IS A GENETIC MODIFIER FOR RISK, AGE OF ONSET AND ALZHEIMER's DISEASE's CONVERSION WHICH MODULATES PATHOLOGY‐RELATED AD BIOMARKERS
Author(s) -
Dea Doris,
Théroux Louise,
Leduc Valerie,
Labonte Anne,
Nilsson Nathalie I.V.,
Poirier Judes
Publication year - 2017
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2017.06.2006
Subject(s) - allele , cohort , medicine , disease , population , statin , reductase , endocrinology , epidemiology , exon , oncology , biology , genetics , enzyme , gene , biochemistry , environmental health
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom